ATEA PHARMACEUTICALS, INC. (AVIR)
Clinical trial NCT06911320 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-04-30 3. primary completion date: 2026-05-01 → 2026-04-30 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06911320 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-04-30 3. primary completion date: 2026-05-01 → 2026-04-30 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical